SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (21729)5/8/1999 9:29:00 AM
From: alan laValley  Read Replies (1) of 23519
 
VLAD: Perhaps going it alone is an entirely different situation today. Wilson has with the advice of the new CFO reduced the expenses drastically and more importantly public awareness of ED has increased dramatically ( although muse is still not a well know product). There appears also enough "cash" to sustain both the R&D & normal business expenses. These events along with reduced pressure to "get it done now" have created a more comfortable situation for VIVUS. Should the stock continue to rise reaching say $8-12 range then I would favor holding off a domestic partner. As the "pipeline" fills with new an exciting products and with each quarter being profitable more credibility will be achieved. This stock as we know is a long term hold 2-4 years. If Wilson can (thats a big if,I know) develop the pipeline to the market, than this stock could easily reach new highs.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News